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The two-stage inflammatory  state observed by Sanarelli (1) and by Shwartz- 
man (2) is considered an interesting, although not entirely understood, reaction 
of tissue. The reaction localized to skin, referred to as the Shwartzman phe- 
nomenon, represents  a  special  type of inflammatory change,  one  requiring 
"preparation" of tissue by intracutaneous injection, usually of an endotoxin 
from Gram-negative bacteria, and "initiation" of the lesions after a specified 
time interval by an intravenous, challenging,  or provoking injection of the 
same or a variety of unrelated substances. Evidence has been offered to indicate 
that polymorphonuclear white blood cells (3), leucocytic-platelet thromboses 
(4),  altered local  enzymatic reactions (3,  5),  and possibly  vascular reactive 
chemical substances,  i. e. adrenaline and serotonin  (6,  7), play a part in pro- 
duction of the hemorrhagic reaction. Upon histologic study, the lesions assume 
a hemorrhagic necrosis and "fibrinoid" change (8)  observed  in many inflam- 
matory patterns which involve connective tissues  (9). And as an experimental 
model,  the  Shwartzman phenomenon has  often been  studied because  of a 
similarity to certain clinical states. 
Observations  by histologic means (9) and experiments  with the use of sul- 
fated polymers (10) have implicated the acid mucopolysaccharides  (MPS)  in 
the pathogenesis  of the lesion produced by the Shwartzman phenomenon.  Up 
to the present time, little information has been available on the changes of the 
MPS in Shwartzman lesions except as observed by histochemical methods. The 
development of technics for isotopically  labeling and for isolating MPS offers 
an opportunity to study the MPS quantitatively. The following experiments 
represent  an  attempt to  evaluate metabolic alterations of the MPS  within 
tissues  involved in the Shwartzman phenomenon. 
* Supported by grants from the American Heart Association and the National Heart 
Institute of the United States Public Health Service. 
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Materials and Methods 
Animals.--Male  rabbits, 4 to 6 pounds in weight and obtained from a  single commercial 
breeder, were used in the experiments. They were maintained on a diet of Purina rabbit pellets 
and water,  given freely. 
Bacterial Endotoxin.--E.  coli endotoxin,  a  trichloracetic acid  soluble fraction  (11),  was 
used throughout the experiments and was supplied through the kindness of Dr. A. Braude of 
the Department of Medicine, University of Pittsburgh Medical School, Pittsburgh. 
Radioactive Compounds.--Uniformly labeled lglucose-Cl4 and C i4 carboxy-labeled sodium 
acetate  ~ prepared from BaCl~O8 were used as precursors of the NIPS.  The administration of 
radioactive compounds will be described in more detail later. 
Production of the Localized Shwartzman Phenomenon.--Since the concentration of MPS in 
skin is low, it was desirable to produce lesions involving large segments of tissue to permit 
isolation of these compounds. Through a series of preliminary experiments, it was found that 
approximately 1.5 mg. of endotoxin administered intracutaneously, followed by 0.3 to 0.5 mg. 
given intravenously, could be tolerated by most of the rabbits studied. The hair on the back 
and sides of the animals was clipped, and the midline was marked. Endotoxin, dissolved in 
isotonic saline (1.0 mg./3 ml.), was distributed unilaterally over a  large area of skin by the 
injection of 12 to  15 discrete intracutaneous wheals, and a  challenging injection of 0.5 rag. 
was given intravenously 20 to 24 hours later. Inflammatory and hemorrhagic areas developed 
at  the sites of intracutaneous preparation and reached a  maximum hemorrhagic intensity 
during the next  24 hours. 
By this procedure of skin preparation and by the pooling of tissue from several 
animals, adequate amounts  of skin could be obtained, and the adjacent hetero- 
lateral  skin,  which  was  not  directly  involved  with  lesions,  could  serve  as  a 
control tissue.  An example of the lesions is shown in Fig.  1. 
Additional animals were handled simultaneously but received no endotoxin. Thus, three 
types of skin samples were obtained: normal skin from control rabbits and Shwartzman lesions 
and unprepared skin from the animals receiving endotoxin. The amount of tissue obtained as 
lesions from an individual rabbit varied according to the number and extent of lesions which 
formed. The variations compared with control sites are indicated in Table I. The lesions, which 
were edematous and hemorrhagic, particularly at 24 hours, lost considerable weight (approxi- 
mately 16 per cent) in preparation for extraction of MPS. 
Isolation of the Mucopolysaccharides.--The MPS were isolated by the method described by 
Schiller and associates (12). Tissues were ground, hemorrhagic fluid was decanted, defatted 
with acetone, and air-dried. Pooled samples of dry-defatted tissues were extracted with alkali 
and digested with trypsin. Protein precipitation was performed with trichloroacetic acid, and a 
crude preparation of MPS was obtained by precipitation with alcohol. The MPS, a mixture, 
was then separated by zone electrophoresis on celite with a  0.1 M PO, buffer, pH 6.9,  into 
two fractions, hyaiuronic acid  (HA)  and chondroitin sulfate  (CSA).  The sulfated fraction 
consists of a  mixture of CSA-A and CSA-B, but primarily B, and in these experiments no 
further attempts were made to fractionate this group. The amount of MPS was determined by 
recovery from the electrophoretic procedure by precipitation and collection of a dried sample 
or by a carbazole determination of hexuronic acid (13). For samples of CSA (which gives low 
1 Obtained from Isotopes Specialties Co., Inc., Burbank, California. 
2 Prepared with the kind assistance of Dr.  J.  Meyer,  Veterans Administration Hospital, 
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values by the carbazole method due to ~iduronic acid in CSA-B), a factor of 1.6 was found 
to give similar values to samples which could be recovered. 
Assay  of Radio~tivity.--The amount of radioactivity  of the  MPS  was determined  by 
combustion to BaCO3 and counting with a continuous gas-flow windowless counter. Quad- 
ruplicate  determinations  were made. Results  were corrected for background, converted to 
"infinite thickness," and expressed as counts per minute. Except for certain samples of CSA, 
discussed below, a counting error within 5 per cent was maintained. 
TABLE I 
Amount of Skin Samples Obtained from RabMts with Shwartzman Lesions and 
from Control Animals 
Study interval 
2 hrs. 
Controls. 
Shwar  tzman experimental 
control skin. 
lesions 
4 hrs. 
Controls. 
Shwartzman experimental 
control skin. 
lesions. 
days 
Controls. 
Shwartzman experimental 
control skin... 
lesions. 
Weight of tissues, 
gm./rabbiff 
Mean 
43.5 
53.6 
26.7 
42.0 
38.8 
26.7 
36.8 
44.6 
21.6 
Range 
(36.1-50.9 ) 
(48.8-58.5) 
(23.7-29.6) 
(30.3-87.0) 
(17.4--89.0) 
(16.0-35.7) 
(27.5-54.4) 
(17.9-67.8) 
(10.2-42.7) 
Dry-defatted tissue, 
per cog of wet weigkt$ 
Mean  Range 
30.5  (28.3-32.7) 
30.7  (28.0-33.4) 
24.0  (20.4-27.5) 
30.4  (28.0-33.6) 
34.0  (30.5-41.3) 
22.3  (20.9-27.1) 
29.7  (24.8-39.4) 
29.9  (27.2-32.2) 
24.2  (21.5-28.3) 
* Half of actual amounts obtained from control animals are shown. Values for the Shwartz- 
man lesions represent amount of tissue after dissection from uninvolved  skin and, if expressed 
on basis of surface area, would be greater than control sites due to inflammatory edema. 
$ Acetone-extracted, ground tissue expressed as per cent of skin samples after grinding. 
Approximately 3 per cent of control tissues was lost in grinding procedure; the percentages 
of tissue,  edema, and hemorrhagic fluid lost for the lesions were 5, 16, and 7 for 12 hour, 24 
hour, and 5 day studies, respectively. 
EXPERIMENTAL 
TWO approaches, with different isotope-labeling methods, were used to study 
the MPS. In one, radioactive glucose was given at the time of the second or 
challenging dose of endotoxin and the imorporation of the radioactive precursor 
into the MPS was observed (14,  15).  Other experiments  used the technic of 
in vitro dilution of previously prepared, radioactive MPS fractions which were 
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Incorporation  of Glucose-C  14 into  the Mucopolysaccharides.--The  method of 
production of the Shwartzman lesions has already been described. Twenty to 
24 hours after the initial preparation of skin sites with endotoxin, the challeng- 
ing intravenous injection of endotoxin was given and, in addition, 20 uc./kg, of 
body weight of radioactive glucose in isotonic saline was administered intra- 
venously to  both prepared  and  control  animals.  The  rabbits  were  usually 
handled in groups of six, two controls and four with lesions. Two or three rab- 
bits which survived the initial preparation with endotoxin, matched by weight 
with one control,  were used for isotope injection. The animals were sacrificed, 
and dorsal skin was harvested at three intervals, 12 hours, 24 hours, and 5 days, 
after injection of glucose and challenging  endotoxin.  This procedure  was re- 
peated with several  groups  until adequate quantities of tissue  could  be ob- 
tained for study. Four rabbits (excluding discarded  animals)  with lesions and 
two control animals supplied adequate tissue for the 12 hour study, six with 
lesions and two controls were used for the 5 day study; samples of tissue for 
the 24 hour period were obtained from a total of twelve animals with lesions 
and four controls in order to perform three complete procedures. The replicate 
experiments  enabled  an  estimate of the variation for over-all  experimental 
conditions  (approximately =t:  12  per  cent).  Since  conditions are  similar,  a 
comparison  can  be  made of more  detailed incorporation studies in normal 
rabbits performed by Schiller and associates (15). Those studies present decay 
curves of the time course of isotope incorporation into MPS adequate to allow 
calculations  of turnover rates. 
Results of the incorporation  experiments  are summarized  in Table II. Most 
apparent is the increased radioactivity in samples obtained from the animals 
with lesions, which demonstrated comparable  radioactivity for tissue directly 
involved in the lesions and for adjacent control skin. An exception to the sym- 
metrical change was observed for CSA from skin lesions of 24 hour duration. 
Differences from normal animals in the amount of incorporation into CSA were 
observed only at the later time intervals. 
Dilution  of  Previously  Labeled Radioactive  Mucopolysaccharides.--Highly 
labeled MPS compounds were prepared by injecting 1.5 inc. of sodium acetate- 
C  ~4 into normal rabbits and sacrificing the animals  24 hours later.  The MPS 
were isolated from skin by the technic described. CSA was also obtained from 
cartilage (predominantly CSA-A) (16) because of the isolation of an inadequate 
quantity of the skin CSA. Although the CSA tracer material is derived from 
another tissue source and is of a different composition, previous studies indicate 
that the compounds  CSA-A and B are frequently isolated  from tissues as  a 
mixture, are  electrophoretically  similar,  and  require  additional technics  for 
their separation (17). 
The carrier  MPS, estimated to be approximately one-tenth the content of 
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quantities of dry-defatted tissue from the three experimental conditions,  skin 
from control rabbits, control skin from rabbits receiving  endotoxin,  and the 
Shwartzman lesions. For these experiments  the skin  to be studied was pooled 
from rabbits not receiving  radioactive precursor.  A total of fifty-six  rabbits 
was used in these studies. The MPS were isolated as described for the incor- 
poration experiments, and their radioactivity was determined. From the degree 
of dilution of radioactivity of exogenous MPS an estimate was made of the 
content of MPS contained in the original samples of tissue. 
TABLE  II 
Incorporation  of Glucose-O  4 into Mucopolysacckarides  of Skwartzman Lesions and 
Control Tissues 
Hyaluronic acid, cou~s/mln.*  Chondroitin sulfate, ¢otmts/mln.* 
Study interval  Shwartzman  experimental  Shwartzmsn experimental 
12 hrs. 
24 hrs. ~: 
5 days 
Controls 
174 
235 
(192-271) 
110 
Control  Les~n 
282  246 
377  433 
(310-411)  (397469) 
243  162 
Controls 
104 
108 
(86-128) 
68 
Control  Lesion 
105  89 
120  229 
(10s-12s)  (208-249) 
125  131 
* Corrected for background and infinite thickness. 
:~ Average values and ranges of radioactivity of mucopolysaccharides from triplicate ex- 
periments. 
The results of three series of experiments  performed with samples of tissue 
obtained at 24 hours and 5 days are presented in Table III. (Two additional 
experiments were performed for the 24 hour period with the use of labeled CSA 
from skin, but, because of inadequate data for CSA fraction, are not presented. 
Results observed  for the HA fraction are similar to those presented in Table 
III.) In general,  the results indicate a considerably greater degree of dilution 
by tissue containing lesions for HA and CSA at both 24 hours and 5 days. 
The data shown in Table IV represent an analysis of the amount of MPS 
isolated in all the experiments. These results are presented for comparison with 
those obtained from the dilution studies. Since the isolation procedures are not 
quantitative, the studies with a dilution technic help corroborate the observa- 
tion that the lesions contained a greater concentration of MPS. Approximately 
50 per cent more HA was isolated from skin involved in Shwartzman lesions 
and, although less consistent, studies of CSA demonstrated almost a  twofold 
increase  in  this fraction. A  slightly greater than normal concentration was 
observed  in the control skin of animals with lesions. 
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of the MPS  from a  technical standpoint is somewhat simpler and is a  more 
reproducible procedure than the studies of dilution of added or carrier MPS. 
Degree  of  incorporation alone, however,  is  not a  valid estimate of  absolute 
change of  the  compounds, and without determination of  amounts, the MPS 
TABLE III 
Dilution of Added Ct4-1abded Mucopolysaccharides* by Isolates  from Shwartzman 
Lesions and Control Tissues 
Study interval 
24 hrs.§ 
Radioactivity, counts/ 
rain. 
Dilution 
Calculated  MPS  con- 
tent,  mg./lO0  gm. 
tissue 
5 daysl] 
Radioactivity, counts/ 
min. 
Dilution 
Calculated  MPS  con- 
tent,  mg./lO0  gm. 
tissue 
Hysluronic  acid 
Controls 
129 
14.8 
296 
122 
(122-123) 
15.3 
306 
Shwartzman 
experimental 
Control  Lesion 
108  78 
17.6  24.5 
352  490 
112  93 
(101-123) (85-101) 
17  20.7 
340  414 
Chondroitin  sulfate~ 
Controls 
25 
4.5 
64 
20.6 
(9.6-31.6) 
5.4 
77 
Shwartzman 
experimental 
Control  Lesion 
l1.9  9.8 
! 
9.4  11.4 
134  163 
1 
8.4  7.9 
(7.2-9.6)  (7.3-8.51 
13.3  14.2 
190  203 
* Seven mg. of hyaluronic acid of 1910 counts/minute and 5 mg. of chondroitin sulfate-A 
of 112 counts/minute were added to each set of alkali-extracted tissue (solubilized 35 gin. 
of dry-defatted skin). 
:~ The low values are not within 5 per cent counting accuracy; however, they are suggestive 
of direction of change. 
§ Results of one experiment. 
[[ Results of duplicate experiments. Values obtained for control animals from 24 hour and 
5 day studies could be considered as triplicate determinations, which indicate reproducibility 
of dilution procedure. 
pools, involved interpretation of actual differences is difficult.  This  becomes 
apparent  from  observations  of  similarity  of  incorporated  radioactivity  of 
fractions from  skin with and without lesions from  the  same animals. Since 
recovery of MPS from tissue is not complete, the use of a  method such as the 
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The problem may arise that the dilution studies are not true tracer experi- 
ments. In the isolation of the MPS fractions considerable degradation occurs. 
After  addition  of  isolated  (partially  degraded  or  lower  molecular  weight) 
compounds,  are  equivalent  amounts  of materials  being  lost  throughout  the 
stages of isolation? Information to answer this question  is not available, but 
it is obvious that the recoveries of the MPS vary widely. Calculated from con- 
tent of MPS  estimated by the dilution  method,  the average recovery of HA 
was approximately 46 (39 to 49) per cent, as compared to 36 (13 to 60) per cent 
TABLE IV 
Amount  of Mucopolysaccharide Isolated from  Skin Containing Shwartzman Lesions and 
Control Sites 
Results are given in mg./lO0 gin. dry-defatted tissue.* 
Study interval 
Controls 
12 hrs.~ 
24 hrs. 
5 days 
(123-168) 
145 
145 
(74-206) 
148 
Hyaluronic acid  Chondroitln sulfate 
Shwartzman experimental  Shwartzmau experimental 
Control  Lesion 
183  307 
172  219 
(72-235)  (85-320) 
134  182 
(83-176)  (131-244) 
i 
Controls 
64 
31 
(24-44) 
46 
(41-51) 
Control  Lesion 
33  81 
33  61 
(27-37)  (53-71) 
23  72 
(17-27)  (53-82) 
* Calculated from weight of compounds isolated or by carbazole determinations. Refer to 
text for further details. 
Results of one experiment. 
for CSA.  Results for normal animals observed in these experiments are in a 
similar range as reported for rats (18). 
The studies of HA, technically, are more satisfactory than for CSA. Several 
reasons may account for the difference. Hyaluronic acid is a  larger molecular 
weight material, the major MPS of skin, and is more easily freed from protein 
in tissue.  Moreover, the tracer HA material in these experiments came from 
the same tissue source and the results are more consistent. For observations of 
CSA by the dilution method, it would have been desirable to use material with 
a  higher level of specific activity. The data of low radioactivity could not be 
considered strictly quantitative in adhering to an accepted 5 per cent variation 
in counting technic. But, despite the limitations a direction of change--one of 
increased  MPS  fractions,  HA and  CSA,  within  the lesions--is indicated  by 
both sets of observations, isolation and MPS  dilution. 
In relating the changes of the MPS within the Shwartzman lesions, one must 
consider the differences of tissue to be extracted. The skin involved in lesions 720  MUCOPOLYSACCHARIDES IN  SHWARTZMAN  PHENOMENON 
was dissected free of uninvolved tissue, and upon gross examination was found 
to be extremely edematous and hemorrhagic. Upon grinding, in preparation 
for extraction of MPS,  a  considerable amount of hemorrhagic fluid was  ex- 
pressed and discarded. The question may be posed whether the necrosis of the 
tissue with destruction of cells  allows a  relatively greater  concentration  of 
connective tissue (MPS-yielding material)  during the process of dehydration 
and defatting with acetone. Necrosis could conceivably result in an apparently 
greater concentration of MPS per dry weight of tissue. Also, another inter- 
pretation may be made if calculations are expressed on original wet  weight 
materials which are given in Table I. If applied, there is no significant change 
in concentration of MPS  within lesions,  but on the  basis  of area  the  total 
amounts may be increased. (Such corrections do not apply to incorporation of 
isotope.  Those  data are  compared  for specific  activity and  are  relative,  ir- 
respective of the condition of tissue extracted or amount of MPS  isolated.) 
However, analyses based on dry weight seem to be the best means for comparing 
the different tissues, since the reduced percentage of residual dried tissue may 
be an artifact due to inflammatory edema. Further evidence that an increased 
concentration of MPS actually occurs is reflected by comparison of both con- 
trols which are similar as dried tissue but different in the calculated content 
of MPS. In addition, the data shown in Table III suggest a continued increase 
of CSA after 5 days; this observation agrees with experiments that demon- 
strate that CSA is synthesized more slowly than is hyaluronic acid (14,  19). 
Another explanation for the increase of MPS is deposition from blood into 
the lesions. That deposition may be a factor is suggested by a higher specific 
activity at 24 hours of CSA samples obtained from lesions than from hetero- 
lateral skin (Table II). CSA has previously been shown to be present in serum 
(20), white blood cells (21), and platelets (22). Incorporation into these sources 
may be more rapid and could contribute to  the isolation of a  more  highly 
labeled compound from hemorrhagic skin.  Unfortunately, comparative rates 
of incorporation for  CSA  from different sources,  including blood,  were  not 
determined and are unavailable in other investigations. The continued increase 
of CSA after 5 days by isolation from tissue with less  hemorrhage, neverthe- 
less, favors primarily an increased rate of synthesis of this compound. 
DISCUSSION 
The  Shwartzman phenomenon has been  studied extensively by histologic 
methods. As part of the necrotic process a "fibrinoid degeneration" is observed, 
which is similar to that seen in many inflammatory reactions involving con- 
nective tissue.  Impressions  from histologic observations  indicate that  MPS 
take part in the reaction; however, beyond information concerning these com- 
pounds obtained by non-specific histochemical technics, little is known of their 
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these compounds with isotopes enable a more direct and quantitative approach 
to determine alterations of the different substances within tissue. Earlier studies 
(23)  of experimental serum sickness  with the use of radioactive acetate re- 
flected only slight increases in incorporation of a precursor without changes in 
the amount of MPS isolated.  A limitation of that study was the selection of 
skin as the source of MPS. Serum sickness produces small (microscopic) vascular 
lesions, and the skin from these animals represented an admixture of diseased 
and  normal  tissue.  Contrary to  this,  the localized  cutaneous lesion  of the 
Shwartzman phenomenon offers good experimental  conditions; gross lesions 
can be produced with adjacent tissue as a control from the same animals. 
The present experiments  suggest metabolic changes, both quantitative and 
qualitative, of two MPS fractions. Of particular interest is the greater than 
normal incorporation of glucose (higher  specific activity) into MPS similarly 
from both lesions and control tissue of animals receiving endotoxin. Although 
the implication has been made that the rate of incorporation is not a  direct 
reflection of pool size of precursors  (24), the results obtained with animals with 
Shwartzman lesions  suggest  the degree  of incorporation to be secondary to 
glucose metabolism altered by illness. It is possible that one unit such as glu- 
cose may be rate-limiting in synthesis of complex MPS. Consequently, caution 
is needed in interpreting incorporation studies and a  direct comparison  with 
normal animals in a steady state may not be valid. In these experiments within 
the limits already discussed, a primary change of MPS occurs in the lesions as 
compared with a control tissue of heterolateral skin. The data may be inter- 
preted as indicating an increased biosynthesis of MPS since the calculations of 
fractional turnover rates were greater both for HA and CSA isolated from the 
lesions (Table V). 
It is interesting to speculate on the role of the MPS in the tissue reactivity 
of the  Shwartzman phenomenon.  Proper  evaluation of these compounds  is 
difficult with currently available information. Although mucopolysaccharides 
are often discussed as a group, uniformity of function cannot be attributed to 
individual MPS,  even  in  a  single  tissue,  such  as  skin.  Striking individual 
differences in  chemical  and physicochemical  properties  are known to  exist. 
For example, a considerable antithrombin activity has been demonstrated for 
CSA-B (fl-heparin) (25), and this physiologic property could be a factor in the 
extensive hemorrhage of the lesions. In addition, these compounds  form part 
of the matrix of blood vessel walls and could be of importance in "intactness" 
of blood vessels. Vascular permeability, although not observed to be abnormal 
in the early phase of development of the Shwartzman reaction (26), could still 
play a role in production of a hemorrhagic lesion. Adhesiveness associated with 
viscosity of MPS may be a factor in formation of platelet and white cell thrombi. 
A number of MPS are also known to compose a part of granulation tissue (27) 
and are metabolically  active in inflammation  provoked by a variety of methods. 722  MUCOPOLYSACCHA~IDES IN  SITWARTZMAN  PHENOMENON 
Thus,  the role of these substances may not be special to Shwartzman  lesions 
but may be part of the inflammatory reaction of tissue to injury. The questions 
which are posed may be clarified by future investigations of connective tissue 
with  improved  methods  of  study. 
TABLE V 
Comparison of Pool Sizes and Turnover Rates of Mucopolysacckarides in Rabbits 
with Strwartzman Lesions and Control Tissues 
Pool size,* mg.[lO0 gin. tissue.. 
Fractional  turnover  rate,~  mg./lO0 
gm./day. 
Hyaluronic  acid 
Controls 
301 
77 
Shwartzman 
experimental 
Control  Lesion 
346  452 
96  126 
Chondroitin sulfate 
Shwartzman 
experimental 
Controls 
Control  Lesion 
70  162  183 
10  19  26 
* Average values obtained from 24 hour and 5 day studies,  which were  determined by a 
dilution method as described in text and presented in Table III. 
tvTol size --The values for turnover rates are rough approximations based on curves ob- 
X  1.44 
tained for three time intervals covering formation and healing of Shwartzman  lesions. The 
curves were constructed by comparison with studies in normal rabbits and estimates of turn- 
over rates of mucopolysaccharides in rats. A summary of those experiments  is presented by 
Dorfman and Schiller (24). The actual decay curves which are derived in normal animals as 
well as in diseased animals are not single exponential,  but the  difficulty  of reproducing de- 
tailed experiments and the little additional information to be gained  justify the simplified 
calculations. 
SUMMARY 
The effect of the Shwartzman  phenomenon  on  the metabolism of the acid 
mucopolysaccharides  (MPS),  hyaluronic  acid  and  chondroitin  sulfate,  from 
rabbits with localized lesions was studied. Quantitative changes of MPS  were 
observed by two techniques--the in vivo incorporation of glucose C 14 into the 
MPS  and  the  in  vitro  dilution  of  C14-1abeled  MPS.  The  results  indicate an 
increased concentration of both MPS fractions in the skin lesions and suggest 
an increased biosynthesis of the compounds at the site of the lesions. Deposition 
of chondroitin sulfate from  blood may have  contributed  in  part  to  the  con- 
centration of this substance in the lesions. The MPS contribute to the inflam- 
matory state of the  Shwartzman phenomenon  but  the specific roles  of  these 
compounds need to be defined by further study. 
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EXPLANATION  OF  PLATE  53 
FIG. 1.  Hemorrhagic lesions of the Shwartzman phenomenon of 24 hour duration 
in the dorsal skin of a rabbit.  Multiple lesions  were produced unilaterally and are 
shown on the subcutaneous surface.  The adjacent heterolateral skin was used in the 
experiments as a control. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 112  PLATE  53 
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